Alcentra Capital Corp. (NASDAQ:ABDC) was downgraded by research analysts at TheStreet from a “b” rating to a “c+” rating in a report released on Monday.

Other equities analysts have also recently issued reports about the company. Keefe, Bruyette & Woods initiated coverage on Alcentra Capital Corp. in a research report on Tuesday, April 11th. They issued a “market perform” rating and a $14.00 price target for the company. DA Davidson assumed coverage on Alcentra Capital Corp. in a research note on Wednesday, July 5th. They set a “buy” rating and a $15.00 price target for the company. Finally, Raymond James Financial, Inc. lowered Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and dropped their price target for the stock from $16.00 to $14.00 in a research note on Monday, July 17th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $13.75.

Shares of Alcentra Capital Corp. (NASDAQ ABDC) traded down 1.57% during mid-day trading on Monday, reaching $11.88. The company had a trading volume of 176,254 shares. Alcentra Capital Corp. has a 52-week low of $11.17 and a 52-week high of $14.73. The firm’s 50-day moving average price is $13.28 and its 200 day moving average price is $13.24.

COPYRIGHT VIOLATION NOTICE: This article was first reported by American Banking News and is owned by of American Banking News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/07/26/alcentra-capital-corp-nasdaqabdc-downgraded-to-c-at-thestreet.html.

In related news, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $13.13, for a total value of $22,213,846.07. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 4.96% of the company’s stock.

Institutional investors have recently added to or reduced their stakes in the stock. Muzinich & Co. Inc. boosted its position in Alcentra Capital Corp. by 98.3% in the first quarter. Muzinich & Co. Inc. now owns 452,913 shares of the asset manager’s stock valued at $6,223,000 after buying an additional 224,537 shares during the period. Ares Management LLC boosted its position in Alcentra Capital Corp. by 3.5% in the first quarter. Ares Management LLC now owns 434,049 shares of the asset manager’s stock valued at $5,964,000 after buying an additional 14,525 shares during the period. UBS Group AG boosted its position in Alcentra Capital Corp. by 20.7% in the first quarter. UBS Group AG now owns 258,940 shares of the asset manager’s stock valued at $3,558,000 after buying an additional 44,387 shares during the period. Confluence Investment Management LLC boosted its position in Alcentra Capital Corp. by 2.7% in the second quarter. Confluence Investment Management LLC now owns 209,528 shares of the asset manager’s stock valued at $2,847,000 after buying an additional 5,566 shares during the period. Finally, Raymond James Financial Services Advisors Inc. boosted its position in Alcentra Capital Corp. by 93.4% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 166,750 shares of the asset manager’s stock valued at $2,291,000 after buying an additional 80,544 shares during the period. 43.58% of the stock is currently owned by institutional investors and hedge funds.

About Alcentra Capital Corp.

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Analyst Recommendations for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.